Immucell (ICCC) EBITDA (2009 - 2026)
Immucell (ICCC) recorded EBITDA of $1.42 million in Q3 2026, up 86.1% from $763,096 a year earlier but down 41.0% from the prior quarter.
Immucell (ICCC) EBITDA (2009 - 2026) Analysis & Trends
On a TTM basis, Immucell's EBITDA came in at $6.99 million as of Sep 30, 2026, up 35.3% year-over-year; for FY2025, it was $4.51 million, up 291.4% from FY2024.
- Annual EBITDA has a five-year compound annual growth rate of 32.9% (FY2020 to FY2025).
- Across earlier years, EBITDA came in at $1.15 million in FY2024, -$2.97 million in FY2023, $223,060 in FY2022 (-91.9%) and $2.75 million in FY2021 (+152.9%).
- Quarterly EBITDA has ranged from -$1.59 million in Q1 2023 to $2.5 million in Q1 2026 over the past five years.
- On a year-over-year basis, EBITDA has increased for three consecutive quarters, with growth averaging 159.9% over the last seven quarters.
- Peak year-over-year performance for EBITDA in the last five years was growth of 502.7% in Q3 2025, against a decline of 97.8% in Q2 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $2.41 million (Q2 2026), $2.5 million (Q1 2026) and $659,449 (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | 8.16 Bn |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | 7.34 Bn |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | 5.99 Bn |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | 4.83 Bn |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | 4.20 Bn |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | 7.05 Bn |
| 10 | Immucell | 102.43 Mn | 75.03 Mn | 3.56 Mn | 1.42 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.42 Mn |
| Jun 30, 2026 | 2.41 Mn |
| Mar 31, 2026 | 2.50 Mn |
| Dec 31, 2025 | 659,449.00 |
| Sep 30, 2025 | 763,096.00 |
| Jun 30, 2025 | 1.26 Mn |
| Mar 31, 2025 | 1.82 Mn |
| Dec 31, 2024 | 1.32 Mn |
| Sep 30, 2024 | 126,614.00 |
| Jun 30, 2024 | -689,260.00 |
| Mar 31, 2024 | 392,471.00 |
| Dec 31, 2023 | 699,849.00 |
| Sep 30, 2023 | -461,485.00 |
| Jun 30, 2023 | -611,086.00 |
| Mar 31, 2023 | -1.59 Mn |
| Dec 31, 2022 | -1.02 Mn |
| Sep 30, 2022 | 24,145.00 |
| Jun 30, 2022 | 18,983.00 |
| Mar 31, 2022 | 1.20 Mn |
| Dec 31, 2021 | 753,349.00 |
Immucell EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=ICCC&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "ICCC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=ICCC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();